Lord, Abbett & Co. LLC

SEC CIK: 0000728100
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overview All 13F holders of BCRX Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2022

Holdings of BCRX by Lord, Abbett & Co. LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−532,350−100.0%	Sold out	Holders
Q2 2025	532,350	$4.77M	<0.1%	+532,350	New	Holders
Q2 2022	0	$0	0.0%	−2,318,016−100.0%	Sold out	Holders
Q1 2022	2,318,016	$37.7M	0.1%	+2,318,016	New	Holders